Índice

• • ·Violence, crime, corruption, and cuts in public spending: how to re-establish cancer control in Latin America?

    Página :1417

     
• • ·9 weeks that matter for patients with gastric cancer

    Página :1418-1419

    Henrik Nienhüser, Thomas Schmidt

     
• • ·Bortezomib-based chemotherapy in mantle cell lymphoma

    Página :1419-1421

    Simon Rule

     
• • ·Genotype-guided fluoropyrimidine dosing: ready for implementation

    Página :1421-1422

    Ursula Amstutz, Carlo R Largiadèr

     
• • ·Avelumab in non-small-cell lung cancer

    Página :1423-1424

    Rafael Rosell, Niki Karachaliou

     
• • ·Long-term survival with anti-PD-1-based immunotherapy, but what is the best approach?

    Página :1424-1426

    Mark R Middleton

     
• • ·Towards improving accuracy, effectiveness, and efficiency in breast cancer screening

    Página :1426-1427

    Martin J Yaffe

     
• • ·Pelvic radiotherapy in prostate cancer: an unresolved question

    Página :1428-1429

    Guila Delouya, Daniel Taussky

     
• • ·The effect of postmastectomy radiotherapy on patient-reported outcomes

    Página :1429-1431

    Eileen Rakovitch, Lawrence Paszat

     
• • ·Personalised approach in follicular lymphoma

    Página :1431-1432

    Stefano Luminari

     
• • ·A step towards dignity in life and death

    Página :e565

    Cassandra Coburn, David Collingridge

    
• • ·Integrating palliative care into health systems is essential to achieve Universal Health Coverage

    Página :e566

    Felicia Marie Knaul

    
• • ·Oncology and palliative care: patients need a seamless service

    Página :e568

    Nigel Sykes

    
• • ·Integration of oncology and palliative care: less-mentioned issues and a Japanese perspective

    Página :e570

    Yu Uneno, Manabu Muto, Tatsuya Morita

    
• • ·Integrating palliative and oncology care: paediatric considerations

    Página :e572

    Angela M Feraco, Joanne Wolfe

    
• • ·Monitoring asparaginase activity

    Página :e574

    Luís Maurício T R Lima, Talita S Araujo, Fábio C L Almeida, Marcius S Almeida

    
• • ·Monitoring asparaginase activity

    Página :e575

    Maria Inez Pordeus Gadelha

    
• • ·Monitoring asparaginase activity – Authors’ reply

    Página :e576

    Mariana Bohns Michalowski, Liane Esteves Daudt, Marcelo Zubaran Goldani

    
• • ·Quality of life after breast reconstruction—the BRIOS study

    Página :e577

    Shelley Potter, Ramsey I Cutress, Elizabeth J Conroy, Chris Holcombe, iBRA Steering Group

    
• • ·Quality of life after breast reconstruction—the BRIOS study

    Página :e578

    Giuseppe Catanuto, Dorin Dumitru, Alberto Rancati, Nicola Rocco, Maurizio Bruno Nava

    
• • ·Quality of life after breast reconstruction—the BRIOS study

    Página :e579

    Zoë E Winters, Ankur Khajuria

    
• • ·The silent victims of the US embargo against Iran

    Página :e580

    Mithra Ghalibafian, Shabnam Hemmati, Eric Bouffet

    
• • ·Correction to Lancet Oncol 2016; 17: 164–73

    Página :e581

    
• • ·Correction to Lancet Oncol 2018; 19: 1192–204

    Página :e581

    
• • ·Correction to Lancet Oncol 2018; 19: 1289–306

    Página :e581

    
• • ·Correction to Lancet Oncol 2018; 19: 1468–79

    Página :e581

    
• • ·Correction to Lancet Oncol 2018; 19: 1504–15

    Página :e581

    
• • ·Correction to Lancet Oncol 2018; 19: 1480–92

    Página :e581

    
• • ·Lurbinectedin for BRCA-mutated advanced breast cancer

    Página :e582

    Elizabeth Gourd

     
• • ·hu3F8 for resistant or recurrent neuroblastoma

    Página :e583

    Talha Khan Burki

     
• • ·Lomustine in older patients with acute myeloid leukaemia

    Página :e584

    Elizabeth Gourd

     
• • ·Brigatinib versus crizotinib for ALK-positive NSCLC

    Página :e585

    Robert Stirrups

     
• • ·Duvelisib in haematological malignancies

    Página :e586

    Manjulika Das

     
• • ·Combination therapy for first relapse of multiple myeloma

    Página :e587

    Elizabeth Gourd

     
• • ·A new perspective: from internal medicine resident to oncologist

    Página :1433

    Adam Yuh Lin, Sheetal Kircher

     
• • ·Should next-generation sequencing testing be routinely used in metastatic colorectal cancer?

    Página :1434-1435

    Rodrigo Dienstmann, Aaron Ciner, Howard S Hochster

    Esquema Esquema  
• • ·Developing cancer care institutions for the developing world

    Página :1436

    Ian Pereira, Matthew S Katz, Richard Simcock

    
• • ·Developing cancer care institutions for the developing world – Investigator’s response

    Página :1436

    Bhawna Sirohi, C S Pramesh, Shailesh V Shrikhande, Susannah Stanway, Richard Sullivan

    
• • ·Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial

    Página :1437-1448

    Kohei Shitara, Toshihiko Doi, Mikhail Dvorkin, Wasat Mansoor, Hendrik-Tobias Arkenau, Aliaksandr Prokharau, Maria Alsina, Michele Ghidini, Catia Faustino, Vera Gorbunova, Edvard Zhavrid, Kazuhiro Nishikawa, Ayumu Hosokawa, ?uayib Yalç?n, Kazumasa Fujitani, Giordano D Beretta, Eric Van Cutsem, Robert E Winkler, Lukas Makris, David H Ilson, Josep Tabernero

    Resumen Resumen Esquema Esquema   
• • ·Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

    Página :1449-1458

    Tadeusz Robak, Jie Jin, Halyna Pylypenko, Gregor Verhoef, Noppadol Siritanaratkul, Johannes Drach, Markus Raderer, Jiri Mayer, Juliana Pereira, Gayane Tumyan, Rumiko Okamoto, Susumu Nakahara, Peter Hu, Carlos Appiani, Sepideh Nemat, Franco Cavalli, LYM-3002 investigators, Achiel Van Hoof, Adriana Sheliga, Adriana Teixeira, Akihiro Tomita, Albert Oriol Rocafiguera, Alexander Suvorov, Alexy Kuzmin, Ali Khojasteh, Amel Mezlini, Anatoly Golenkov, Andre Bosly, Andrew Belch, Ann Van De Velde, Árpád Illes, Ashis Mukhopadhyay, Balkis Meddeb, Bernard De Prijck, Bernardo Garichochea, Bulent Undar, Caballero Gabarrón, Carmen Cao, Carmino Souza, Charles Farber, Cheol Won Suh, Cristina Ileana Burcoveanu, Cristina Ligia Cebotaru, Cristina-Ligia Truica, Dai Maruyama, David Belada, Dina Ben Yehuda, Dmitry Udovitsa, Enrica Morra, Ernst Späth-Schwalbe, Eva Gonzalez-Barca, Evgenii Osmanov, Francisco Javier Capote, Fritz Offner, Galvez Cardenas, Georg Heß, Georgii Manikhas, Govind Babu, Grigoriy Rekhtman, Guiseppe Rossi, Herlander Marques, Horia Bumbea, Huaqing Wang, Huiqiang Huang, Ilseung Choi, Irina Bulavina, Irina Lysenko, Irit Avivi, Iryna Kryachok, Jan Maciej Zaucha, Jan Novak, Joaquín Díaz, Judit Demeter, Julia Alexeeva, Jun Zhu, Kateryna Vilchevskaya, Kenichi Ishizawa, Kenny Mauricio, Kensei Tobinai, Kiyoshi Ando, Kudrat Abdulkadryrov, Lee-Yung Shih, Lyudmila Kuzina, Mahmut Gumus, Maike De Wit, Marcelo Capra, Margarida Marques, Marina Golubeva, Mario Ojeda-Uribe, Maryna Kyselyova, Masafumi Taniwaki, Massimo Federico, Michael Crump, Michele Baccarani, Michinori Ogura, Miklós Egyed, Miklos Udvardy, Mitsutoshi Kurosawa, Naokuni Uike, Nuriet Khuageva, Ofer Shpilberg, Oleg Gladkov, Olga Samoilova, Olga Serduk, Patricia Santi, Pierre Zachee, Polina Kaplan, Razvan Stoia, Remy Gressin, Reyes Arranz, Richard Greil, Sebastian Grosicki, Sergio Cancelado, Sreejith Nair, Steven Le Gouill, Steven Van Steenweghen, Sung-Soo Yoon, Suporn Chuncharune, Tatiana Scheider, Tatsu Shimoyama, Ting Liu, Tomohiro Kinoshita, Toshiki Uchida, Udomsak Bunworasate, Umberto Vitolo, Viacheslav Pavlov, Vijay Rao Phooshkooru, Vladimir Lima, Vladimir Merkulov, Weerasak Nawarawong, Xiaonan Hong, Xiaoyan Ke, Yasuhito Terui, Yeow Tee Goh, Yoshiharu Maeda, Yuankai Shi, Yuri Dunaev, Yurii Lorie, Zhao Wang, Zhixiang Shen, Zita Borbenyi, Zoltán Gasztonyi, Zvenyslava Masliak

    Resumen Resumen Esquema Esquema   
• • ·DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

    Página :1459-1467

    Linda M Henricks, Carin A T C Lunenburg, Femke M de Man, Didier Meulendijks, Geert W J Frederix, Emma Kienhuis, Geert-Jan Creemers, Arnold Baars, Vincent O Dezentjé, Alexander L T Imholz, Frank J F Jeurissen, Johanna E A Portielje, Rob L H Jansen, Paul Hamberg, Albert J ten Tije, Helga J Droogendijk, Miriam Koopman, Peter Nieboer, Marlène H W van de Poel, Caroline M P W Mandigers, Hilde Rosing, Jos H Beijnen, Erik van Werkhoven, André B P van Kuilenburg, Ron H N van Schaik, Ron H J Mathijssen, Jesse J Swen, Hans Gelderblom, Annemieke Cats, Henk-Jan Guchelaar, Jan H M Schellens

    Resumen Resumen Esquema Esquema   
• • ·Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study

    Página :1468-1479

    Fabrice Barlesi, Johan Vansteenkiste, David Spigel, Hidenobu Ishii, Marina Garassino, Filippo de Marinis, Mustafa Özgüro?lu, Aleksandra Szczesna, Andreas Polychronis, Ruchan Uslu, Maciej Krzakowski, Jong-Seok Lee, Luana Calabrò, Osvaldo Arén Frontera, Barbara Ellers-Lenz, Marcis Bajars, Mary Ruisi, Keunchil Park

    Resumen Resumen Esquema Esquema   
• • ·Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

    Página :1480-1492

    Frank Stephen Hodi, Vanna Chiarion-Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Charles Lance Cowey, Christopher D Lao, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier Francesco Ferrucci, Michael Smylie, Andrew Hill, David Hogg, Ivan Marquez-Rodas, Joel Jiang, Jasmine Rizzo, James Larkin, Jedd D Wolchok

    Resumen Resumen Esquema Esquema   
• • ·One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study

    Página :1493-1503

    Sophia Zackrisson, Kristina Lång, Aldana Rosso, Kristin Johnson, Magnus Dustler, Daniel Förnvik, Hannie Förnvik, Hanna Sartor, Pontus Timberg, Anders Tingberg, Ingvar Andersson

    Resumen Resumen Esquema Esquema  
• • ·Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial

    Página :1504-1515

    Mack Roach, Jennifer Moughan, Colleen A F Lawton, Adam P Dicker, Kenneth L Zeitzer, Elizabeth M Gore, Young Kwok, Michael J Seider, I-Chow Hsu, Alan C Hartford, Eric M Horwitz, Kosj Yamoah, Christopher U Jones, Jeff M Michalski, W Robert Lee, Thomas M Pisansky, Rachel Rabinovitch, Marvin Rotman, Rodger M Pryzant, Harold E Kim, Charles R Thomas, William U Shipley, Howard M Sandler

    Resumen Resumen Esquema Esquema   
• • ·Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial

    Página :1516-1529

    Galina Velikova, Linda Jane Williams, Sarah Willis, J Michael Dixon, Juliette Loncaster, Matthew Hatton, Jacqueline Clarke, Ian H Kunkler, Nicola S Russell, MRC SUPREMO trial UK investigators, A Alhasso, D Adamson, H Algurafi, R Allerton, C Anandadas, A Bahl, L Barraclough, P Barrett-Lee, U Barthakur, C Bedi, M Beresford, J Bishop, G Blackman, P Bliss, D Bloomfield, M Blunt, T Branson, L Brazil, A Brunt, A Chakrabarti, A Chittalie, M Churn, J Clarke, S Cleator, P Crellin, F Danwata, S De-Silva-Minor, A Dhadda, A Eicholz, I Fernando, J Forrest, J Fraser, K Geropantas, A Goodman, R Grieve, M Griffin, M Hadaki, A Hall, M Hatton, J Hicks, S Hignett, M Hogg, R Jyothirmayi, M Khan, S Kumar, P Lawton, D Lee, C Lewinski, C Lim, I Locke, J Loncaster, G Lumsden, S Lupton, B Magee, J Marshall, S Masinghe, C McGregor, M McLennan, P Memtsa, D Milanovic, V Misra, N Mithal, MB Mukesh, A Neal, S Needleman, M Persic, M Quigley, S Raj, P Riddle, D Ritchie, F Roberts, P Robson, H Roe, M Rolles, N Shah, R Sharma, E Sherwin, P Simmonds, G Skailles, S Skaria, W Soe, R Sripadam, A Stevens, A Stockdale, N Storey, N Storey, I Syndikus, N Thorp, N Thorp, S Upadhyay, M Varughese, N Walji, R Welch, T Wells, V Wolstenholme, V Wolstenholme, P Woodings, F Yuille

    Resumen Resumen Esquema Esquema   
• • ·Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

    Página :1530-1542

    Judith Trotman, Sally F Barrington, David Belada, Michel Meignan, Robert MacEwan, Carolyn Owen, Václav Ptá?ník, András Rosta, Günter R Fingerle-Rowson, Jiawen Zhu, Tina Nielsen, Deniz Sahin, Wolfgang Hiddemann, Robert E Marcus, Andrew Davies, PET investigators from the GALLIUM study, Mark Hertzberg, Andrew Grigg, Paul Cannell, Hang Quach, Stephen Opat, Constantine Tam, Paula Marlton, Ann Janssens, Fritz Offner, Koen Van eygen, Randeep Sangha, Pam Mckay, Jonathan Wilson, Richard Van Der Jagt, Daryl Roitman, Marek Trneny, Jiri Mayer, Katell Le Du, Philippe Solal-Celigny, Guillaume Cartron, Charles Foussard, Norbert Frickhofen, Peter Schmidt, Ullrich Graeven, Tobias Gaska, Rudolf Schlag, Martin Sökler, Gabriele Prange-Krex, Axel Florschütz, Hans-Walter Lindemann, Christoph Schimmelpfennig, Solveig Tonndorf, Mathias Hänel, Georg Hess, Enrico Schalk, Heiko Hütten, Gottfried Doelken, Michael Pfreundschuh, Ulrich Keller, Michael Herold, Roswitha Forstpointner, Ursula Vehling-Kaiser, Martin Hoffmann, Zita Borbenyi, Miklos Udvardy, Judit Demeter, Alessandro Rambaldi, Enrica Morra, Federico Massimo, Ignazio Majolino, Monica Balzarotti, Gianpietro Semenzato, Miguel Angel Canales Albendea, Francisco Javier Peñalver Parraga, Alfonso Soler Campos, Juan Manuel Sancho Cia, Jose Antonio Marquez Navarro, Carlos Grande Garcia, Herman Nilsson-Ehle, Helen Mccarthy, Chris Pocock, Shalal Sadullah, Ram Malladi, John Radford, Ed Kanfer, Anton Kruger, Dominic Culligan, Martin Dyer, Ruth Pettengell, John Seymour, John Gribben, Saad Al-Ismail, Faris Al-Refaie, Norbert Blesing, Christopher Macnamara, Ann O’callaghan, Andrew Haynes, George Follows, Roderick Johnson, David Cunningham, Kristian Bowles, Graham Collins, Eve Gallop-Evans, Stephen Robinson, Chezhian Subash, James Bailey, Viran Holden, Jeffrey Neidhart, Moacyr De Oliveira, Haluk Tezcan, Kevin Kim, Suman Kambhampati, Keith Lanier, John Mcclean, Kensei Tobinai, Kiyohiko Hatake, Michinori Ogura, Toshiki Uchida, Kiyoshi Ando, Tomohiro Kinoshita, Thomas Höhler, Heribert Stauder, Andreas Kirsch, Michael Koenigsmann, Stephan Kremers, Thomas Illmer, Mathias Witzens-Harig, Paul La Roseé, Jan Dürig, Michael Kneba, Manfred Hensel, Stefan Fuxius, Lothar Bergmann, Kai Hübel, Christian Buske, Reinhard Marks, Gerald Wulf, Christian Lerchenmueller, Rudolf Schmits, Mark Reinwald, Eva Lengfelder, Fiona Scott, Takaaki Chou, Masafumi Taniwaki, Isao Yoshida, Kenichi Ishizawa, Naokuni Uike, Nobuhiko Uoshima, Yuri Kamitsuji, Shinsuke Iida, Ken Ohmine, Kisato Nosaka, Kazuhiko Ide, Takayuki Ishikawa, Pierre Desjardins, Nicholas Finn, Jun Zhu, Wei Li, Li Yu, Hanyun Ren, Yuan Kai Shi, Gang Wu, Xiaonan Hong, Qingyuan Zhang, Jifeng Feng, Rong Zhan, Tongyu Lin, Sirpa Leppa, Regis Costello, Adrian Tempescul, Laurence Sanhes, Olivier Tournilhac, Heinz Kirchen, Holger Hebart, Rudolf Weide, Kathleen Jentsch-Ullrich, Irit Avivi, Arnon Nagler, Ronit Gurion, Ofer Shpilberg, Pietro Leoni, Luca Baldini, Olga Samoylova, Alexandr Myasnikov, Tran-Der Tan, Hung Chang, Kyoya Kumagai, Norifumi Tsukamoto, Kunihiro Tsukasaki, Patrick Beatty, Noriko Usui, Koji Izutsu, Tohru Murayama, Tatsuo Ichinohe, Kohmei Kubo, Fumihiro Ishida, J. Thaddeus Beck, Frank Griesinger, Dzhelil Osmanov, Shaker Dakhil, Aline Clavert, Dai Maruyama, Yasuhito Terui, Kazuhito Yamamoto, Ekkehard Eigendorff, Tsutomu Kobayashi, Satoshi Ichikawa, Ilseung Choi, Katsuya Wada, Yoshitaka Kikukawa, Masao Matsuoka, Takayuki Yoshino, Yosuke Minami

    Resumen Resumen Esquema Esquema   
• • ·Integration of oncology and palliative care: a Lancet Oncology Commission

    Página :e588

    Stein Kaasa, Jon H Loge, Matti Aapro, Tit Albreht, Rebecca Anderson, Eduardo Bruera, Cinzia Brunelli, Augusto Caraceni, Andrés Cervantes, David C Currow, Luc Deliens, Marie Fallon, Xavier Gómez-Batiste, Kjersti S Grotmol, Breffni Hannon, Dagny F Haugen, Irene J Higginson, Marianne J Hjermstad, David Hui, Karin Jordan, Geana P Kurita, Philip J Larkin, Guido Miccinesi, Friedemann Nauck, Rade Pribakovic, Gary Rodin, Per Sjøgren, Patrick Stone, Camilla Zimmermann, Tonje Lundeby

    Resumen Resumen Esquema Esquema  
• • ·Retrorectal tumour

    Página :e654

    Takeshi Kondo